Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.057 0.1
mRNA CIL70 CTRPv2 pan-cancer AAC 0.072 0.1
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.052 0.1
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.1
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.067 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.051 0.1
mRNA staurosporine CTRPv2 pan-cancer AAC -0.11 0.1
mRNA ATRA GDSC1000 pan-cancer AAC -0.053 0.1
mRNA BX-912 GDSC1000 pan-cancer AAC 0.047 0.1
Download CSV